Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) Management of Bullous Keratopathy After PreserFlo MicroShunt Device: A Case Report and Literature Review

Descemet膜剥离自动内皮角膜移植术(DSAEK)治疗PreserFlo MicroShunt装置植入术后大疱性角膜病:病例报告及文献综述

阅读:1

Abstract

Bullous keratopathy is a known complication following glaucoma filtration surgeries, and Descemet's stripping automated endothelial keratoplasty (DSAEK) has been reported as an effective management approach in several cases. However, management of bullous keratopathy in eyes with minimally invasive bleb surgery (MIBS) devices presents unique challenges. We report the first successful case of DSAEK in a patient with bullous keratopathy following PreserFlo MicroShunt (PMS) (Santen Pharmaceutical Co., Ltd., Osaka, Japan) implantation, with additional complications of prior vitrectomy for malignant glaucoma. The patient, a 69-year-old male, had undergone bilateral pseudoexfoliative glaucoma surgery, and subsequent DSAEK was performed, resulting in favorable postoperative outcomes despite the challenging presentation. This case demonstrates the feasibility of endothelial keratoplasty in eyes with PreserFlo devices and crucial insights for surgical management, including our modified technique with limited central Descemet's membrane stripping, shortening of the PMS device, and utilization of a thinner donor graft to overcome the unique challenges associated with glaucoma drainage devices.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。